7 май 2020 г. - RCT (Preprint) - HCQ in patients with
mild to moderate COVID–19
Описание:
"The results of our trial did not show additional benefits of virus elimination by adding HCQ to the current SOC in patients mainly with persistent mild to moderate COVID–19." [26]
Добавлено на ленту времени:
Дата: